ralinepag

ralinepag: developed by 2 companies · 1 clinical trial tracked. Updated within the last hour.

Development Pipeline (2)

Clinical Trials (1)

A Phase 3 Open-label Extension (OLE) Study to Evaluate the Long-term Safety and Efficacy of Ralinepag in Subjects With World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension (PAH)

NCT03683186·Phase 3·UTHR
Enrolling by invitation

Frequently asked questions

Who is developing ralinepag?

ralinepag is being developed by ARENA PHARMACEUTICALS INC, UNITED THERAPEUTICS Corp.

How many clinical trials involve ralinepag?

BioSniper tracks 1 clinical trial involving ralinepag.

Get deeper analysis on ralinepag

Full trial data, mechanism of action, competitive landscape, and AI-powered insights.

Start Free Analysis
    ralinepag — Drug Pipeline, Trials & FDA Status | BioSniper